Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q1 2025 · 10-Q
Revenue$92.82M$92.82M+22.9% vs Q1 2024 Net Income-$256.58M-$256.58MN/M vs Q1 2024 EPS Diluted-$1.42-$1.42N/M vs Q1 2024 Operating Income-$248,140,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
Free Cash Flowderived-$272,158,000N/M Margins · derivedOperating margin-267.3%−74.6 pt vs Q1 2024
Net margin-276.4%−68.4 pt vs Q1 2024
ended Mar 31, 2025 · filed May 8, 2025 · 38 d after period end